Pharma Journalist -

Mustang Bio, Inc., a clinical-stage biopharmaceutical company focused on cell therapies for hard-to-treat cancers, announced that the U.S. Food and Drug Administration (FDA) has granted…
Read More...

Swiss biopharmaceutical company BioVersys AG has entered into a global research and exclusive license option agreement with Japanese pharmaceutical firm Shionogi & Co., Ltd. to…
Read More...

Brii Biosciences Limited, a biotechnology company focused on addressing high unmet medical needs, has announced a licensing and technology transfer agreement with Joincare…
Read More...

Jazz Pharmaceuticals plc announced that the European Commission (EC) has granted conditional marketing authorization for Ziihera® (zanidatamab), a dual HER2-targeted bispecific…
Read More...

Merck, known as MSD outside the U.S. and Canada, announced that the U.S. Food and Drug Administration (FDA) has accepted and granted priority review to a supplemental Biologics License…
Read More...

The U.S. Food and Drug Administration (FDA) has granted accelerated approval to ZEGFROVY (sunvozertinib), a novel oral therapy developed by Dizal, for the treatment of adults with…
Read More...

Adagene Inc., a biotechnology company developing innovative antibody-based cancer therapies, announced that Sanofi will invest up to $25 million in the company as part of an expanded…
Read More...

Regeneron Pharmaceuticals, Inc. announced that the U.S. Food and Drug Administration (FDA) has granted accelerated approval for Lynozyfic (linvoseltamab-gcpt) to treat adult patients…
Read More...

The Japanese Ministry of Health, Labour and Welfare (MHLW) has granted orphan drug designation to riliprubart, an investigational monoclonal antibody developed by Sanofi, for the…
Read More...

Sobi announced that the U.S. Food and Drug Administration (FDA) approved Gamifant (emapalumab-lzsg) for the treatment of adult and pediatric (newborn and older) patients with…
Read More...